Guobang Pharma Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Guobang Pharmaceutical Group Co., Ltd. (stock abbreviation: Guobang Pharmaceutical, stock code: 605507) is a pharmaceutical manufacturing company that faces the global market, has multiple varieties, and has various key intermediate production capabilities. It is an important participant in the global chemical pharmaceutical manufacturing industry chain and one of the top 100 enterprises in China's pharmaceutical industry. The company is mainly engaged in the research and development, production, and sales of related products in the field of pharmaceuticals and animal health products. The pharmaceutical sector covers pharmaceutical raw materials, key pharmaceutical intermediates and preparations, while the animal health products sector covers animal health raw materials, animal health additives and preparations. The company adheres to the principle of unifying technology services for life, economic benefits, and social benefits, following the development of the pharmaceutical industry, and has formed a comprehensive advantage of "one system, two platforms" in long-term stable development. Relying on platform advantages, driven by innovation, and based on a lean management system, it has significant scale advantages in the international and domestic markets, and has good synergistic effects in sales. The company has a global marketing network and products are sold to 115 countries and regions worldwide, covering a population of 6.5 billion. The company's industrial bases are located in the Zhejiang Xinchang Provincial High tech Industrial Park, Zhejiang Hangzhou Bay Shangyu Economic and Technological Development Zone, and Shandong Weifang Binhai Economic and Technological Development Zone. The subordinate enterprises include Zhejiang Guobang Pharmaceutical Co., Ltd., Shandong Guobang Pharmaceutical Co., Ltd., Zhejiang Dongying Pharmaceutical Co., Ltd., Xinchang Hebao Biotechnology Co., Ltd., Zhejiang Zhongtong Pharmaceutical Co., Ltd., Zhejiang Zhongtong Technology Co., Ltd., Zhejiang Guobang Modern Pharmaceutical Co., Ltd., Hangzhou Guobang Enterprise Management Co., Ltd., Xinchang Guobang Import and Export Co., Ltd., and Hangzhou Yifan Import and Export Co., Ltd., with a total of over 3000 employees, Various production and business land covers over 2500 acres. The company has been awarded the title of "Top 100 Enterprises with Comprehensive Strength in the Industrial Enterprises of China's Chemical and Pharmaceutical Industry"; The All China Federation of Industry and Commerce Medical and Pharmaceutical Industry Chamber of Commerce is one of the top 100 enterprises in the Chinese pharmaceutical industry; China Chamber of Commerce for the Import and Export of Medical and Health Products as a "high-quality supplier and partner in the international market"; Honorary titles such as "Top 10 Export Member Enterprises of China's Western Pharmaceutical Raw Materials Industry" by the China Chamber of Commerce for Import and Export of Medical and Health Products. |
| Headquarter | Shaoxing |
| Establish Date | 3/29/1996 |
| Listed Code | 605507.SH |
| Listed Date | 8/2/2021 |
| Chairman | Qiu Jiajun. |
| CEO | Liao Shixue. |
| Website | www.gbgcn.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
